Germany Passes Healthcare Cost Reform Amid Pharma Opposition
German lawmakers approved a major reform to reduce statutory health insurance costs, despite opposition from pharmaceutical companies and political divisions in parliament. The bill includes measures such as higher mandatory rebates for drugmakers, capped hospital expenses, and tying healthcare spending growth to economic expansion.
Topics: government policy healthcare reform pharmaceutical industry impact